Adding sulphonylureas (SUs) to metformin remains a commonly used strategy for treating type 2 diabetes, but individual SUs differ and may confer different risks of abnormally low blood sugar, or…
A new study from Belgium indicates that the majority of community-dwelling elderly adults are taking prescription medications inappropriately. The study, which is published in the British Journal of…
The lay press and thousands of nutritional products warn of oxygen radicals or oxidative stress and suggest taking so-called antioxidants to prevent or cure disease. Professor Pietro Ghezzi at the…
In March 2016, the Society had responded to the call for evidence for the Research Excellence Framework (REF) review by Lord Nicholas Stern to highlight particular areas of concern…
The Society had conributed to the Royal Society of Biology's response to the Teaching Excellence Framework technical consultation for year 2. This consultation, which was published…
New research reveals that two specific plant-derived compounds may be effective for fighting inflammation and pain. The findings are published in the British Journal of Pharmacology.Diterpenoids are…
Safety concerns of the concomitant use of clopidogrel with the proton pump inhibitors (PPIs) omeprazole or esomeprazole were published in May 2009 and February 2010 by European regulatory agencies.…
A new review examines the potential of antioxidant approaches for the treatment of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and…
A recent analysis indicates that adding new therapies called anti-PCSK9 antibodies to other lipid-lowering treatments can help patients lower their LDL cholesterol levels. Mutations in the gene that…
The Society is a global community at the heart of pharmacology, with over 3,500 members from over 60 countries. Our members are the heart of our Society and ensure that we can continue to lead the…
